158 related articles for article (PubMed ID: 17082176)
21. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
[TBL] [Abstract][Full Text] [Related]
22. Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis.
Raimondi S; Botteri E; Iodice S; Lowenfels AB; Maisonneuve P
Mutat Res; 2009 Nov; 670(1-2):6-14. PubMed ID: 19589345
[TBL] [Abstract][Full Text] [Related]
23. Role of EPHX genotype in the associations of smoking and diet with colorectal adenomas.
Tiemersma EW; Kloosterman J; Bunschoten A; Kok FJ; Kampman E
IARC Sci Publ; 2002; 156():491-3. PubMed ID: 12484240
[No Abstract] [Full Text] [Related]
24. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study.
Hirose M; Kono S; Tabata S; Ogawa S; Yamaguchi K; Mineshita M; Hagiwara T; Yin G; Lee KY; Tsuji A; Ikeda N
Cancer Sci; 2005 Aug; 96(8):513-8. PubMed ID: 16108833
[TBL] [Abstract][Full Text] [Related]
25. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
[TBL] [Abstract][Full Text] [Related]
26. Lack of influence of the ADH1B Arg47His genetic polymorphism on risk of colorectal adenoma in middle-aged Japanese men.
Yin G; Hamajima N; Morita M; Tajima O; Tabata S; Kono S
Asian Pac J Cancer Prev; 2011; 12(1):297-302. PubMed ID: 21517275
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
[TBL] [Abstract][Full Text] [Related]
28. Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society.
Sahin O; Arikan S; Oltulu YM; Coskunpinar E; Eren A; Cacina C; Guler E; Yaylim I
Genet Test Mol Biomarkers; 2012 May; 16(5):423-8. PubMed ID: 22352736
[TBL] [Abstract][Full Text] [Related]
29. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
[TBL] [Abstract][Full Text] [Related]
30. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
Giovannucci E; Chen J; Smith-Warner SA; Rimm EB; Fuchs CS; Palomeque C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):970-9. PubMed ID: 14578131
[TBL] [Abstract][Full Text] [Related]
31. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.
Tabata S; Yin G; Ogawa S; Yamaguchi K; Mineshita M; Kono S
Cancer Sci; 2006 May; 97(5):406-10. PubMed ID: 16630139
[TBL] [Abstract][Full Text] [Related]
33. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
34. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.
Andersen V; Agerstjerne L; Jensen D; Østergaard M; Saebø M; Hamfjord J; Kure E; Vogel U
BMC Med Genet; 2009 Feb; 10():18. PubMed ID: 19250544
[TBL] [Abstract][Full Text] [Related]
35. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
36. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
37. Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas.
Tiemersma EW; Wark PA; Ocké MC; Bunschoten A; Otten MH; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):419-25. PubMed ID: 12750236
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
40. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
